The so-called “Angelina Jolie effect” has undoubtedly led to better social awareness of familial cancer syndromes and has resulted in an increase in the number of women inquiring about genetic screening to determine whether they are at a higher risk of developing breast and ovarian cancer because of mutations in the BRCA1 and BRCA2 genes [3-5]. Here, BRCA1 is linked to ovarian cancer.